REFERENCES
2. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin 2000;50:7-33.
3. Nentwich MF, Bockhorn M, Konig A, Izbicki JR, Cataldegirmen G. Surgery for advanced and metastatic pancreatic cancer--current state and trends. Anticancer Res 2012;32:1999-2002.
4. Mann O, Strate T, Schneider C, Yekebas EF, Izbicki JR. Surgery for advanced and metastatic pancreatic cancer--current state and perspectives. Anticancer Res 2006;26:681-6.
5. Treasure T. Oligometastatic cancer: an entity, a useful concept, or a therapeutic opportunity? J R Soc Med 2012;105:242-6.
6. Damanakis AI, Ostertag L, Waldschmidt D, et al. Proposal for a definition of “Oligometastatic disease in pancreatic cancer”. BMC Cancer 2019;19:1261.
7. Lu F, Poruk KE, Weiss MJ. Surgery for oligometastasis of pancreatic cancer. Chin J Cancer Res 2015;27:358-67.
8. Tempero MA, Malafa MP, Al-Hawary M, et al. Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2017;15:1028-61.
9. Hackert T, Niesen W, Hinz U, et al. Radical surgery of oligometastatic pancreatic cancer. Eur J Surg Oncol 2017;43:358-63.
10. Michalski CW, Erkan M, Huser N, Muller MW, Hartel M, Friess H, Kleeff J. Resection of primary pancreatic cancer and liver metastasis: a systematic review. Dig Surg 2008;25:473-80.
11. Bockhorn M, Cataldegirmen G, Kutup A, et al. Crossing the Rubicon: when pancreatic resection with curative intent ends in an R2 status. Impact of “desmoplastic pseudo-pancreatitis” and anatomical site of irresectability. Ann Surg Oncol 2009;16:1212-21.
12. D’Haese JG, Renz BW, Ilmer M, Werner J. Surgery for isolated local recurrence and metachronous oligometastasis in pancreatic cancer. Chirurg 2020;91:628-35.
13. Yamamoto S, Sato Y, Takeishi T, et al. Liver transplantation in an endostage cirrhosis patient with abdominal compartment syndrome following a spontaneous rectus sheath hematoma. J Gastroenterol Hepatol 2004;19:118-9.
14. Van Oudheusden TR, Grull H, Dankers PY, De Hingh IH. Targeting the peritoneum with novel drug delivery systems in peritoneal carcinomatosis: a review of the literature. Anticancer Res 2015;35:627-34.
15. Sugarbaker PH. Strategies to improve local control of resected pancreas adenocarcinoma. Surg Oncol 2017;26:63-70.
16. Staribratova D, Zaprianov Z, Uchikov A. Adenocarcinoma of the pancreas with distant meningeal metastasis. Khirurgiia (Sofiia) 2009:48-51.
17. Maeno T, Satoh H, Ishikawa H, et al. Patterns of pancreatic metastasis from lung cancer. Anticancer Res 1998;18:2881-4.
18. Kocic M, Nikolic S, Zegarac M, et al. Prognostic factors and outcomes of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer - A single tertiary institution experience. J BUON 2016;21:1176-83.
19. Embuscado EE, Laheru D, Ricci F, et al. Immortalizing the complexity of cancer metastasis: genetic features of lethal metastatic pancreatic cancer obtained from rapid autopsy. Cancer Biol Ther 2005;4:548-54.
20. Tsurusaki M, Numoto I, Oda T, et al. Assessment of Liver Metastases Using CT and MRI Scans in Patients with Pancreatic Ductal Adenocarcinoma: Effects of Observer Experience on Diagnostic Accuracy. Cancers (Basel) 2020;12.
21. Danet IM, Semelka RC, Nagase LL, Woosely JT, Leonardou P, Armao D. Liver metastases from pancreatic adenocarcinoma: MR imaging characteristics. J Magn Reson Imaging 2003;18:181-8.
22. Renz BW, Boeck S, Roeder F, Trumm C, Heinemann V, Werner J. Oligometastatic Disease in Pancreatic Cancer - How to Proceed? Visc Med 2017;33:36-41.
24. Hasuike Y, Tanigawa T, Yamada M, et al. A case report-advanced pancreas cancer with liver and lung metastases well controlled over one year by combination therapy with systemic chemotherapy, radiation and hepatic arterial infusion in an outpatient setting. Gan To Kagaku Ryoho 2008;35:2117-9.
25. Schullian P, Johnston EW, Putzer D, et al. Stereotactic radiofrequency ablation (SRFA) for recurrent colorectal liver metastases after hepatic resection. Eur J Surg Oncol 2020. S0748-7983(20)30806-4
26. Lee SJ, Kim JH, Kim SY, Won HJ, Shin YM, Kim PN. Percutaneous Radiofrequency Ablation for Metachronous Hepatic Metastases after Curative Resection of Pancreatic Adenocarcinoma. Korean J Radiol 2020;21:316-24.
27. Sparchez Z, Mocan T, Hajjar NA, et al. Percutaneous ultrasound guided radiofrequency and microwave ablation in the treatment of hepatic metastases. A monocentric initial experience. Med Ultrason 2019;21:217-24.
28. Tachezy M, Gebauer F, Janot M, et al. Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysis. Surgery 2016;160:136-44.
29. Frigerio I, Regi P, Giardino A, et al. Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery? Ann Surg Oncol 2017;24:2397-403.
30. Klein F, Puhl G, Guckelberger O, et al. The impact of simultaneous liver resection for occult liver metastases of pancreatic adenocarcinoma. Gastroenterol Res Pract 2012;2012:939350.
31. Alghamdi AA, Hasabullah MA, Alhusani AI, et al. Survival Outcome of Pulmonary Metastasectomy Among Patients with Sarcoma and Colorectal Primary Cancers: A Single Institute Experience. Gulf J Oncolog 2018;1:56-60.
32. Nanji S, Karim S, Tang E, et al. Pulmonary metastasectomy for colorectal cancer: predictors of survival in routine surgical practice. Ann Thorac Surg 2018;105:1605-12.
33. Ampollini L, Gnetti L, Goldoni M, et al. Pulmonary metastasectomy for colorectal cancer: analysis of prognostic factors affecting survival. J Thorac Dis 2017;9:S1282-S90.
34. Arnaoutakis GJ, Rangachari D, Laheru DA, et al. Pulmonary resection for isolated pancreatic adenocarcinoma metastasis: an analysis of outcomes and survival. J Gastrointest Surg 2011;15:1611-7.
35. Klempnauer J, Ridder GJ, Piso P, Pichlmayr R. Is liver resection in metastases of exocrine pancreatic carcinoma justified? Chirurg 1996;67:366-70.
36. Robinson LA, Tanvetyanon T, Springett G, et al. Pulmonary metastasectomy for suspected pancreaticobiliary cancer. J Thorac Cardiovasc Surg 2016;152:75-82.
37. Downs-Canner S, Zenati M, Boone BA, et al. The indolent nature of pulmonary metastases from ductal adenocarcinoma of the pancreas. J Surg Oncol 2015;112:80-5.
38. Yamashita K, Miyamoto A, Hama N, Asaoka T, Maeda S, Omiya H, Takami K, Doki Y, Mori M, Nakamori S. Survival Impact of Pulmonary Metastasis as Recurrence of Pancreatic Ductal Adenocarcinoma. Dig Surg 2015;32:464-71.
39. Wei M, Shi S, Hua J, Xu J, Yu X; Chinese Study Group for Pancreatic C. Simultaneous resection of the primary tumour and liver metastases after conversion chemotherapy versus standard therapy in pancreatic cancer with liver oligometastasis: protocol of a multicentre, prospective, randomised phase III control trial (CSPAC-1). BMJ Open 2019;9:e033452.
